1. SMC1 promotes epithelial-mesenchymal transition in triple-negative breast cancer through upregulating Brachyury
   KAICHUN LI et al, 2016, Oncology Reports CrossRef
2. Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer
   Shinichiro Shimamatsu et al, 2016, Annals of Surgical Oncology CrossRef
3. The design of 1,4-naphthoquinone derivatives and mechanisms underlying apoptosis induction through ROS-dependent MAPK/Akt/STAT3 pathways in human lung cancer cells
   Yi Zhang et al, 2019, Bioorganic & Medicinal Chemistry CrossRef
4. Role of T‐box genes in cancer, epithelial‐mesenchymal transition, and cancer stem cells
   Gengle Niu et al, 2022, Journal of Cellular Biochemistry CrossRef
5. Design of an In Vitro Model for Epithelial-to-Mesenchymal Transition in Gastric Cancer
   Yuanhui Zhang et al, 2024, Biochemical Genetics CrossRef
6. The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells
   Chao Shao et al, 2015, Biochemical and Biophysical Research Communications CrossRef
7. T-box transcription factor brachyury promotes tumor cell invasion and metastasis in non-small cell lung cancer via upregulation of matrix metalloproteinase 12
   ZONGMIAO WAN et al, 2016, Oncology Reports CrossRef
8. Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack
   Duane H. Hamilton et al, 2018, Frontiers in Oncology CrossRef
9. Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer
   Sagar R. Shah et al, 2017, Cell Reports CrossRef
10. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways
    Ling‑Qi Meng et al, 2017, Molecular Medicine Reports CrossRef
11. Low levels of AMPK promote epithelial‐mesenchymal transition in lung cancer primarily through HDAC4‐ and HDAC5‐mediated metabolic reprogramming
    Shoujie Feng et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
12. Brachyury oncogene is a prognostic factor in high‐risk testicular germ cell tumors
    F. Pinto et al, 2018, Andrology CrossRef
13. The Roles of Embryonic Transcription Factor BRACHYURY in Tumorigenesis and Progression
    Ming Chen et al, 2020, Frontiers in Oncology CrossRef
14. Multiple malignant tumors in a patient with familial chordoma, a case report
    Nuttavut Sumransub et al, 2021, BMC Medical Genomics CrossRef
15. Emerging target discovery and drug repurposing opportunities in chordoma
    Daniel M. Freed et al, 2022, Frontiers in Oncology CrossRef